CAS: 1346607-05-3

Gsk621

GSK621 is a specific and potent AMPK activator.

GSK621 is a selective inhibitor, which is synthesized for research purposes in the modulation of enzymatic activity. This compound is sourced through synthetic chemical processes and designed to selectively target the phosphoinositide 3-kinase (PI3K) pathway. GSK621's mode of action involves the inhibition of the PI3K pathway, a critical signaling pathway involved in cellular functions such as growth, proliferation, and survival. By inhibiting this pathway, GSK621 can modulate aberrant signaling commonly observed in various cancers. The applications of GSK621 are primarily in the realm of cancer research, where scientists explore the therapeutic potential of targeting PI3K in different cancer types. Its use in preclinical studies aids in understanding PI3K-related mechanisms in tumorigenesis and evaluating the compound’s efficacy and safety profiles. GSK621 serves as a valuable tool for dissecting the complexities of PI3K signaling and its implications in oncology, providing insights that could inform the development of novel therapeutic strategies.

GSK621